Corbus Pharmaceuticals Holdings, Inc.
CRBP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001595097
In the last 90 days, Corbus Pharmaceuticals Holdings, Inc. insiders filed 1 open-market purchase and 3 sales; 107 institutions reported holding it in 13F filings for Q2 2026, worth $129.1M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Corbus Pharmaceuticals Holdings, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 27 | 34 | +7 |
| Shares | 743.0K | 749.7K | +6.67K (+0.9%) |
| Value | $5.01M | $4.53M | −$478.4K (−9.6%) |
New holders (8)
Institutions that held Corbus Pharmaceuticals Holdings, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tower Research Capital LLC (TRC) | 1,190 | $7.19K | 0.00% |
| Citigroup Inc | 566 | $3.42K | 0.00% |
| BFSG, LLC | 61 | $369 | 0.00% |
| Baystate Wealth Management LLC | 16 | $97 | 0.00% |
| Scarborough Advisors, LLC | 6 | $36 | 0.00% |
| Bank of America Corp | 4 | $24 | 0.00% |
| CWM, LLC | 3 | $0 | 0.00% |
| Keener Financial Planning LLC | 6 | $0 | 0.00% |
Sold out (1)
Institutions that held Corbus Pharmaceuticals Holdings, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| NBC Securities, Inc. | 33 | $0 |